A meta-analysis of nonsense mutations causing human genetic disease

Human Mutation

Volumn 29, Issue 8, 2008, Pages 1037-1047

  Mort, Matthew ^a   Ivanov, Dobril ^a   Cooper, David N ^a   Chuzhanova, Nadia A ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Germline; Human genetic disease; Nonsense mutation; Nonsense mediated mRNA decay; Somatic; Tumor suppressor genes

Indexed keywords

DINUCLEOTIDE;

ARTICLE; BASE PAIRING; CODON USAGE; CPG ISLAND; DEAMINATION; FRAMESHIFT MUTATION; GENETIC SELECTION; GENETIC TRAIT; GERM LINE; HUMAN; METHYLATION; MISSENSE MUTATION; MUTATION RATE; NONSENSE MUTATION; ONCOGENE; PRIORITY JOURNAL; RNA DEGRADATION; RNA TRANSLATION; SOMATIC MUTATION; STOP CODON; TUMOR SUPPRESSOR GENE;

CODON; CODON, NONSENSE; DATABASES, GENETIC; GENETIC DISEASES, INBORN; HUMANS; RNA STABILITY;

EID: 49149098054     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20763     Document Type: Article

References (43)

1. Amrani N, Dong S, He F, Ganesan R, Ghosh S, Kervestin S, Li C, Mangus DA, Spatrick P, Jacobson A. 2006. Aberrant termination triggers nonsense-mediated mRNA decay. Biochem Soc Trans 34:39-42.
2. Anczuków O, Ware MD, Buisson M, Zetoune AB, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S. 2008. Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins? Hum Mutat 29:65-73.
3. Arkov AL, Korolev SV, Kisselev LL. 1995. 5′ contexts of Escherichia coli and human termination codons are similar. Nucleic Acids Res 23:4712-4716.
4. Behm-Ansmant I, Kashima I, Rehwinkel J, Sauliere J, Wittkopp N, Izaurralde E. 2007. mRNA quality control: an ancient machinery recognizes and degrades mRNAs with nonsense codons. FEBS Lett 581:2845-2853.
5. Cassan M, Rousset JP. 2001. UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals. BMC Mol Biol 2:3.
6. Chang YF, Imam JS, Wilkinson MF. 2007. The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76:51-74.
7. Cheung LW, Lee YF, Ng TW, Ching WK, Khoo US, Ng MK, Wong AS. 2007. CpG/CpNpG motifs in the coding region are preferred sites for mutagenesis in the breast cancer susceptibility genes. FEBS Lett 581:4668-4674.
8. Cridge AG, Major LL, Mahagaonkar AA, Poole ES, Isaksson LA, Tate WP. 2006. Comparison of characteristics and function of translation termination signals between and within prokaryotic and eukaryotic organisms. Nucleic Acids Res 34:1959-1973.
9. Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.
10. Gilchrist MA. 2007. Combining models of protein translation and population genetics to predict protein production rates from codon usage patterns. Mol Biol Evol 24:2362-2372.
11. Ho MS, Tsang KY, Lo RL, Susic M, Mäkitie O, Chan TW, Ng VC, Sillence DO, Boot-Handford RP, Gibson G, Cheung KM, Cole WG, Cheah KS, Chan D. 2007. COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type Schmid. Hum Mol Genet 16:1201-1215.
12. Hosack DA, Dennis G, Jr, Sherman BT, Lane HC, Lempicki RA. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70.
13. Hu X, Peek R, Plomp A, ten Brink J, Scheffer G, van Soest S, Leys A, de Jong PT, Bergen AA. 2003. Analysis of the frequent R1141X mutation in the ABCC6 gene in seudoxanthoma elasticum. Invest Ophthalmol Vis Sci 44:1824-1829.
14. Inácio A, Silva AL, Pinto J, Ji X, Morgado A, Almeida F, Faustino P, Lavinha J, Liebhaber SA, Romao L. 2004. Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay. J Biol Chem 279:32170-32180.
15. Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, Mancias P, Butler IJ, Wilkinson MF, Wegner M, Lupski JR. 2004. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 36:361-369.
16. Isken O, Maquat LE. 2007. Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev 21:1833-1856.
17. Jacobs GH, Rackham O, Brown CM. 2002. Transterm: a database of mRNAs and translational control elements. Nucleic Acids Res 30:310-311.
18. Kellermayer R. 2006. Translational readthrough induction of pathogenic nonsense mutations. Eur J Med Genet 49:445-450.
19. Khajavi M, Inoue K, Lupski JR. 2006. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14:1074-1081.
20. Krawczak M, Ball EV, Cooper DN. 1998. Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am J Hum Genet 63:474-488.
21. Kuzmiak HA, Maquat LE. 2006. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 12:306-316.
22. Laux DE, Curran EM, Welshons WV, Lubahn DB, Huang TH. 1999. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas. Breast Cancer Res Treat 56:35-43.
23. Maquat LE. 2004 Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 5:89-99.
24. McCaughan KK, Brown CM, Dalphin ME, Berry MJ, Tate WP. 1995. Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc Natl Acad Sci USA 92:5431-5435.
25. Millar DS, Krawczak M, Cooper DN. 1998. Variation of site-specific methylation patterns in the factor VIII (F8C) gene in human sperm DNA. Hum Genet 103:228-233.
26. Nagy E, Maquat LE. 1998. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 23:198-199.
27. Nakamura Y, Gojobori T, Ikemura T. 2000. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 28:292.
28. Namy O, Hatin I, Rousset JP. 2001. Impact of the six nucleotides downstream of the stop codon on translation termination. EMBO Rep 2:787-793.
29. Olshen AB, Jain AN. 2002. Deriving quantitative conclusions from microarray expression data. Bioinformatics 18:961-970.
30. Ozawa Y, Hanaoka S, Saito R, Washio T, Nakano S, Shinagawa A, Itoh M, Shibata K, Carninci P, Konno H, Kawai J, Hayashizaki Y, Tomita M. 2002. Comprehensive sequence analysis of translation termination sites in various eukaryotes. Gene 300:79-87.
31. Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian development. Science 293:1089-1093.
32. Romão L, Inacio A, Santos S, Avila M, Faustino P, Pacheco P, Lavinha J. 2000. Nonsense mutations in the human β-globin gene lead to unexpected levels of cytoplasmic mRNA accumulation. Blood 96:2895-2901.
33. Schneider TG, Stephens RM. 1990. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18:6097-6100.
34. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN. 2003. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21:577-581.
35. Stockklausner C, Breit S, Neu-Yilik G, Echner N, Hentze MW, Kulozik AE, Gehring NH. 2006. The uORF-containing thrombopoietin mRNA escapes nonsense-mediated decay (NMD). Nucleic Acids Res 34:2355-2363.
36. Sun J, Chen M, Xu J, Luo J. 2005. Relationships among stop codon usage bias, its context, isochores, and gene expression level in various eukaryotes. J Mol Evol 61:437-444.
37. Tate WP, Poole ES, Horsfield JA, Mannering SA, Brown CM, Moffat JG, Dalphin ME, McCaughan KK, Major LL, Wilson DN. 1995. Translational termination efficiency in both bacteria and mammals is regulated by the base following the stop codon. Biochem Cell Biol 73:1095-1103.
38. Tate WP, Eoole ES, Dalphin ME, Major LL, Crawford DJ, Mannering SA. 1996. The translational stop signal: codon with a context, or extended factor recognition element? Biochimie 78:945-952.
39. Thein SL. 2004. Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol 124:264-274.
40. Tornaletti S, Pfeifer GP. 1995. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene 10:1493-1499.
41. Wilkie AOM. 2003. Dominance and recessivity. In: Cooper DN, editor. Nature Encyclopedia of the Human Genome, vol. 2. London: Nature Publishing Group. p 204-213.
42. Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG. 2004. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64:1975-1986.
43. Zhang J, Maquat LE. 1997. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells. EMBO J 16:826-833.